<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">19580782</PMID>
        <DateCompleted>
            <Year>2009</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2104</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>387</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2009</Year>
                        <Month>Sep</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biochemical and biophysical research communications</Title>
                <ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>202-6</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbrc.2009.07.007</ELocationID>
            <Abstract>
                <AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder characterized by degeneration of motor neurons throughout the central nervous system. Mutations of the free radical scavenging enzyme superoxide dismutase-1 (SOD1) are a cause of familial ALS but it is not known how mutations lead to cell death. Free radicals such as nitric oxide (NO) are thought to play a key pathogenic role. NO is synthesized by NO synthases (NOSs) from arginine, which is a rate-limiting factor for NO production. We found that neuronal NOS (nNOS)-positive motor neurons were depleted while inducible NOS (iNOS)-positive activated glial cells were increased in transgenic mtSOD1 (G93A) ALS mice. iNOS expression was up regulated consistent with the increases of motor neuron loss and glial activation and citrulline and NO levels while nNOS expression was decreased in G93A ALS mice. Administration of l-arginine to G93A mice reduced the severity of motor neuron depletion and glial activation. In treated animals, nNOS expression was preserved while citrulline and NO were reduced, possibly due to reduced activation of glia expressing iNOS. Our findings show that high concentrations of NO correlate with iNOS expression rather than nNOS expression in G93A ALS mice. This suggests that therapy focused on iNOS inhibition might be a fruitful direction for future ALS therapeutic trials.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Junghee</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA. junghee@bu.edu</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ryu</LastName>
                    <ForeName>Hoon</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kowall</LastName>
                    <ForeName>Neil W</ForeName>
                    <Initials>NW</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P30 AG 13846</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P30 AG013846-11</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P30 AG013846</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 NS052724</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>NS 52724</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 NS052724-04</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2009</Year>
                <Month>07</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biochem Biophys Res Commun</MedlineTA>
            <NlmUniqueID>0372516</NlmUniqueID>
            <ISSNLinking>0006-291X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>29VT07BGDA</RegistryNumber>
                <NameOfSubstance UI="D002956">Citrulline</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>31C4KY9ESH</RegistryNumber>
                <NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>94ZLA3W45F</RegistryNumber>
                <NameOfSubstance UI="D001120">Arginine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.14.13.39</RegistryNumber>
                <NameOfSubstance UI="D052248">Nitric Oxide Synthase Type I</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.14.13.39</RegistryNumber>
                <NameOfSubstance UI="D052247">Nitric Oxide Synthase Type II</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.14.13.39</RegistryNumber>
                <NameOfSubstance UI="C496321">Nos1 protein, mouse</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.14.13.39</RegistryNumber>
                <NameOfSubstance UI="C496317">Nos2 protein, mouse</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.15.1.1</RegistryNumber>
                <NameOfSubstance UI="C109415">SOD1 G93A protein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.15.1.1</RegistryNumber>
                <NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName>
                <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002956" MajorTopicYN="N">Citrulline</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D052248" MajorTopicYN="N">Nitric Oxide Synthase Type I</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D052247" MajorTopicYN="N">Nitric Oxide Synthase Type II</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName>
                <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2009</Year>
                <Month>06</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2009</Year>
                <Month>07</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2009</Year>
                <Month>7</Month>
                <Day>8</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2009</Year>
                <Month>7</Month>
                <Day>8</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2009</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">19580782</ArticleId>
            <ArticleId IdType="pii">S0006-291X(09)01328-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbrc.2009.07.007</ArticleId>
            <ArticleId IdType="pmc">PMC2742676</ArticleId>
            <ArticleId IdType="mid">NIHMS130297</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Amino Acids. 2003 Jul;25(1):69-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12836061</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem J. 1998 Nov 15;336 ( Pt 1):1-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9806879</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol Methods. 1980;32(4):375-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7358996</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 1996 Jul;17(1):63-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8755479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuropharmacology. 2008 Jun;54(7):1112-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18436268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroinflammation. 2006 Jan 25;3:2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16436205</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosci Lett. 1993 Apr 30;153(2):121-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7687046</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Pharmacother. 2004 Apr;5(4):735-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15102560</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>NIDA Res Monogr. 1993;136:258-71; discussion 271-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7507221</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CNS Drugs. 2003;17(10):699-717</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12873154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1993 Aug 12;364(6438):584</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8350919</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2001 May 31;344(22):1688-700</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11386269</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1993 Mar 4;362(6415):59-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8446170</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1993 Aug 12;364(6438):626-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8394509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6368-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1648740</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Dev Physiol. 1991 Jan;15(1):53-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1678755</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FASEB J. 2009 Jun;23(6):1739-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19179380</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FASEB J. 2004 Aug;18(11):1261-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15208263</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 2005 Jun;93(5):1087-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15934930</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Neurol. 1994 Oct;129(2):335-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7525335</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2003 Apr;53(4):423-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12666108</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 1999 Jun;72(6):2415-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10349851</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4843-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12655043</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Enzymol. 2008;440:177-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18423217</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2009 Jul 10;384(4):524-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19427829</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1993 May 20;363(6426):266-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8487864</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
